11/5
12:33 pm
abcl
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "hold" rating re-affirmed by analysts at Benchmark Co..
Low
Report
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "hold" rating re-affirmed by analysts at Benchmark Co..
11/5
12:33 pm
abcl
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "hold" rating re-affirmed by analysts at Benchmark Co..
Low
Report
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "hold" rating re-affirmed by analysts at Benchmark Co..
11/5
12:31 pm
abcl
Rating for ABCL
Low
Report
Rating for ABCL
11/5
12:31 pm
abcl
Rating for ABCL
Low
Report
Rating for ABCL
11/5
11:20 am
abcl
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $12.00 price target on the stock, down previously from $14.00.
Low
Report
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $12.00 price target on the stock, down previously from $14.00.
11/5
11:20 am
abcl
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $12.00 price target on the stock, down previously from $14.00.
Low
Report
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $12.00 price target on the stock, down previously from $14.00.
11/5
10:46 am
abcl
Rating for ABCL
Low
Report
Rating for ABCL